Related Experiment Video
Updated: Mar 22, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Coagulation disorders and their cutaneous presentations: Pathophysiology
Yunyoung Chang1, Ganary Dabiri2, Elizabeth Damstetter1
1Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.
Insights
Hypercoagulable states increase thrombosis risk. Dermatologists can identify these conditions through skin symptoms, improving patient outcomes by reducing related morbidity and mortality.
Area of Science:
- Hematology
- Dermatology
- Pathophysiology
Background:
- Hypercoagulable states are inherited or acquired conditions predisposing individuals to thrombosis.
- Understanding these states involves analyzing the complex coagulation cascade.
- Cutaneous manifestations can be early indicators of underlying hypercoagulable conditions.
Purpose of the Study:
- To review the epidemiology and pathophysiology of hypercoagulable states.
- To highlight the critical role of dermatologists in identifying and managing these conditions.
- To provide a foundation for understanding clinical features, diagnostics, and treatment in the accompanying article.
Main Methods:
- Literature review focusing on epidemiology and pathophysiology.
- Analysis of the coagulation cascade in relation to thrombotic events.
- Correlation of dermatological presentations with hypercoagulable states.
Main Results:
- Hypercoagulable states represent a significant risk factor for both venous and arterial thromboses.
- Early recognition of cutaneous symptoms by dermatologists can lead to timely diagnosis.
- Understanding pathophysiology is key to comprehending the predisposition to clot formation.
Conclusions:
- Dermatologists are pivotal in the early diagnosis and management of hypercoagulable states.
- Identifying skin manifestations can significantly reduce patient morbidity and mortality.
- This review provides essential epidemiological and pathophysiological context for hypercoagulable states.
Abstract:
Hypercoagulable states are inherited or acquired predispositions to venous or arterial thromboses that are best understood in the context of the coagulation cascade. Dermatologists can play a critical role in diagnosing and treating patients with hypercoagulable states because cutaneous symptoms may be a presenting manifestation, thereby reducing morbidity and mortality related to these conditions. This review focuses on the epidemiology and pathophysiology of hypercoagulable states, while the accompanying article iterates the basic clinical features, diagnostic testing, and management of patients who have these conditions.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

